Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

Leap Therapeutics, Inc. (LPTX) President and CEO, Douglas E. Onsi, to participate in fireside chat at Piper Sandler 35th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35^th Annual Healthcare Conference in New York, NY.

Leap Presentation Details:

Piper Sandler 35^th Annual Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 8:00 a.m. Eastern Time

A live webcast of the fireside chat may be accessed on the Investors page of the company's website at https://investors.leaptx.com/, where a replay of the events will also be available for a limited time.

About Leap Therapeutics
Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-301, is a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Leap also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15. For more information about Leap Therapeutics, visit http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via https://investors.leaptx.com/.

CONTACT:

Douglas E. Onsi
President & Chief Executive Officer
Leap Therapeutics, Inc.
617-714-0360
donsi@leaptx.com

Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-therapeutics-to-participate-at-piper-sandler-35th-annual-healthcare-conference-301991880.html

SOURCE Leap Therapeutics, Inc.

FAQ

When is Leap Therapeutics, Inc. participating in the Piper Sandler 35th Annual Healthcare Conference?

Leap Therapeutics, Inc. is participating in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.

What time will the fireside chat take place?

The fireside chat will take place at 8:00 a.m. Eastern Time.

Where can the live webcast of the fireside chat be accessed?

The live webcast of the fireside chat can be accessed on the Investors page of Leap Therapeutics, Inc.'s website at https://investors.leaptx.com/.

Will a replay of the events be available?

Yes, a replay of the events will also be available for a limited time on the company's website.